Clinical Trial

Published on 24 May 2024

Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

in Neuropharmacology

Khlood Mohammad Aldossary
Lashin Saad Ali
Mahmoud S. Abdallah
Mostafa M. Bahaa
Thanaa A. Elmasry
Eman I. Elberri
Fedaa A. Kotkata
Ramy M. El Sabaa
Yasmine M. Elmorsi
Mostafa M. Kamel

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1381523

1,568 views
1 citation

Review

Published on 24 May 2024

Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

in Neuropharmacology

Chinenye Edith Muolokwu
Bivek Chaulagain
Avinash Gothwal
Arun Kumar Mahanta
Benjamin Tagoe
Babita Lamsal
Jagdish Singh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1405423

3,075 views
1 citation

Systematic Review

Published on 24 May 2024

Global research status and trends of enteric glia: a bibliometric analysis

in Neuropharmacology

Huai-Yu Li
Wei-Xin Yan
Jia Li
Jing Ye
Zhi-Guo Wu
Zheng-Kun Hou
Bin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1403767

1,610 views

Review

Published on 24 May 2024

Alzheimer’s disease and its treatment–yesterday, today, and tomorrow

in Neuropharmacology

A. Y. Kim
S. Al Jerdi
R. MacDonald
C. R. Triggle

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399121

5,747 views
3 citations

Original Research

Published on 23 May 2024

Effects of long-term antipsychotic medication on brain instability in first-episode schizophrenia patients: a resting-state fMRI study

in Neuropharmacology

Maoxing Zhong
Zhening Liu
Feiwen Wang
Jun Yang
Eric Chen
Edwin Lee
Guowei Wu
Jie Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387123

940 views

Original Research

Published on 22 May 2024

Pre-clinical evaluation of clinically relevant iPS cell derived neuroepithelial stem cells as an off-the-shelf cell therapy for spinal cord injury

in Neuropharmacology

Dania Winn
Elias Uhlin
Malin Kele
Ilse Eidhof
Anna Falk

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1390058

1,002 views

Review

Published on 22 May 2024

Drug-induced musical hallucination

in Neuropharmacology

Brock Bakewell
Michael Johnson
Madison Lee
Elizabeth Tchernogorova
Jesse Taysom
Qing Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1401237

2,729 views

Original Research

Published on 22 May 2024

Small pouches, but high nicotine doses—nicotine delivery and acute effects after use of tobacco-free nicotine pouches

in Neuropharmacology

Nadja Mallock-Ohnesorg
Andrea Rabenstein
Yvonne Stoll
Marcus Gertzen
Benedikt Rieder
Sebastian Malke
Nestor Burgmann
Peter Laux
Elke Pieper
Thomas Schulz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1392027

7,280 views
1 citation

Review

Published on 21 May 2024

Mushroom-derived bioactive components with definite structures in alleviating the pathogenesis of Alzheimer’s disease

in Neuropharmacology

Xue Jiang
Yu Song
Changshun Lv
Yinghui Li
Xiangru Feng
Hao Zhang
Yujuan Chen
Qingshuang Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1373660

1,296 views

Original Research

Published on 16 May 2024

Antiseizure properties of fenamate NSAIDs determined in mature human stem-cell derived neuroglial circuits

in Neuropharmacology

Hamed Salmanzadeh
Robert F. Halliwell

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1385523

994 views

Editorial

Published on 15 May 2024

Editorial: Substance use disorder: above and beyond addiction

in Neuropharmacology

Jaya Kumar
Wael Mohamed
Dasiel Oscar Borroto-Escuela
Muthuraju Sangu
Rusdi Rashid
Mohd Fadzli Mohamad Isa
Prem Kumar Shanmugam

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426351

825 views

Original Research

Published on 10 May 2024

Comprehensive spectroscopic and computational insight into the binding of vanillin with human transferrin: targeting neuroinflammation in Alzheimer’s disease therapeutics

in Neuropharmacology

Mohammed Alrouji
Sabina Yasmin
Fahad A. Alhumaydhi
Sharaf E. Sharaf
Moyad Shahwan
Mohammad Furkan
Rizwan Hasan Khan
Anas Shamsi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397332

1,223 views
2 citations

Review

Published on 06 May 2024

Teriparatide: an innovative and promising strategy for protecting the blood-spinal cord barrier following spinal cord injury

in Neuropharmacology

Moliang Xiong
Yun Feng
Caiguang Luo
Jia Guo
Jihuan Zeng
Liang Deng
Qiang Xiao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1386565

1,278 views
1 citation

Original Research

Published on 02 May 2024

Exosomes derived from HUVECs alleviate ischemia-reperfusion induced inflammation in neural cells by upregulating KLF14 expression

in Neuropharmacology

Jianxin Qin
Lihong Zhou
Lei Yu
Jingwen Ye
Feng Wang
Jin Zhou
Yunjuan Gu
Gang Chen
Xia Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1365928

1,204 views

Original Research

Published on 01 May 2024

Exploring the link between pyrethroids exposure and dopaminergic degeneration through morphometric, immunofluorescence, and in-silico approaches: the therapeutic role of chitosan-encapsulated curcumin nanoparticles

in Neuropharmacology

Badriyah S. Alotaibi
Amany Abdel-Rahman Mohamed
Yasmina M. Abd-Elhakim
Ahmed E. Noreldin
Moustafa Elhamouly
Tarek Khamis
Ali H. El-Far
Manal E. Alosaimi
Naief Dahran
Leena S. Alqahtani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388784

1,687 views
1 citation

Editorial

Published on 29 Apr 2024

Editorial: Exploring the key targets and compounds that manipulate brain neurocircuits against mental disorders and psychiatric

in Neuropharmacology

Weijie Xie
Song Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411528

718 views

Navigation group

Articles

Effect of a high dose atorvastatin as added-on therapy on symptoms and serum AMPK/NLRP3 inflammasome and IL-6/STAT3 axes in patients with major depressive disorder: randomized controlled clinical study

Functionalized nanoparticles to deliver nucleic acids to the brain for the treatment of Alzheimer’s disease

Global research status and trends of enteric glia: a bibliometric analysis

Alzheimer’s disease and its treatment–yesterday, today, and tomorrow

Effects of long-term antipsychotic medication on brain instability in first-episode schizophrenia patients: a resting-state fMRI study

Pre-clinical evaluation of clinically relevant iPS cell derived neuroepithelial stem cells as an off-the-shelf cell therapy for spinal cord injury

Drug-induced musical hallucination

Small pouches, but high nicotine doses—nicotine delivery and acute effects after use of tobacco-free nicotine pouches

Mushroom-derived bioactive components with definite structures in alleviating the pathogenesis of Alzheimer’s disease

Antiseizure properties of fenamate NSAIDs determined in mature human stem-cell derived neuroglial circuits

Editorial: Substance use disorder: above and beyond addiction

Comprehensive spectroscopic and computational insight into the binding of vanillin with human transferrin: targeting neuroinflammation in Alzheimer’s disease therapeutics

Teriparatide: an innovative and promising strategy for protecting the blood-spinal cord barrier following spinal cord injury

Exosomes derived from HUVECs alleviate ischemia-reperfusion induced inflammation in neural cells by upregulating KLF14 expression

Exploring the link between pyrethroids exposure and dopaminergic degeneration through morphometric, immunofluorescence, and in-silico approaches: the therapeutic role of chitosan-encapsulated curcumin nanoparticles

Editorial: Exploring the key targets and compounds that manipulate brain neurocircuits against mental disorders and psychiatric